首页|硝苯地平联合拉贝洛尔治疗对妊娠期高血压子痫前期患者血压、生活质量、血流动力学指标的影响研究

硝苯地平联合拉贝洛尔治疗对妊娠期高血压子痫前期患者血压、生活质量、血流动力学指标的影响研究

扫码查看
目的 针对妊娠期高血压(PIH)子痫前期患者采用硝苯地平联合拉贝洛尔治疗,观察其对患者血压、生活质量及血流动力学指标的影响。方法 80例PIH子痫前期患者,按照随机数字表法分为观察组和对照组,每组40例。对照组采用硝苯地平口服治疗,观察组在对照组基础上联合拉贝洛尔治疗。比较两组患者临床疗效、血压、生活质量、脐动脉血流动力学指标、不良妊娠结局发生情况。结果 观察组临床治疗总有效率95。00% 高于对照组的75。00%,差异有统计学意义(x2=6。275,P=0。012<0。05)。治疗后,两组收缩压、舒张压均较治疗前下降,且观察组收缩压(123。12±8。94)mm Hg(1 mm Hg=0。133 kPa)、舒张压(81。75±7。15)mm Hg均低于对照组的(136。16±9。46)、(90。14±8。36)mm Hg,差异有统计学意义(P<0。05)。治疗后,两组患者物质功能、躯体状况、社会功能、心理职能评分均较治疗前提高,且观察组患者物质功能评分(76。38±4。67)分、躯体状况评分(73。73±4。27)分、社会功能评分(78。48±5。75)分、心理职能评分(84。22±4。74)分高于对照组的(62。48±5。05)、(64。38±3。78)、(71。25±4。76)、(74。64±4。62)分,差异具有统计学意义(P<0。05)。治疗后,两组患者血液粘稠度、红细胞比积、阻力指数均较治疗前降低,且观察组患者血液粘稠度(3。58±0。43)mPa·s、红细胞比积(33。28±1。73)%、阻力指数(0。25±0。07)均低于对照组的(4。44±0。36)mPa·s、(40。27±2。03)%、(0。56±0。07),差异具有统计学意义(P<0。05)。随访结果显示,观察组不良妊娠结局发生率5。00% 低于对照组的22。50%,差异具有统计学意义(P<0。05)。结论 PIH子痫前期患者行硝苯地平联合拉贝洛尔治疗,可改善血压及脐动脉血流动力学指标,提高患者生活质量,改善妊娠结局。
A study on the effect of nifedipine combined with labetalol on blood pressure,quality of life and hemodynamic indexes in patients with pregnancy induced hypertension and preeclampsia
Objective To observe the effect of nifedipine combined with labetalol on blood pressure,quality of life and hemodynamic indexes in patients with pregnancy induced hypertension (PIH) and preeclampsia.Methods 80 patients with PIH and preeclampsia were divided into an observation group and a control group according to random numerical table,with 40 cases in each group.The control group was treated with oral nifedipine,and the observation group was treated with labetalol on the basis of the control group.The clinical efficacy,blood pressure,quality of life,umbilical artery hemodynamic indicators,and adverse pregnancy outcomes were compared between the two groups.Results The total clinical effective rate of 95.00% in the observation group was higher than 75.00% in the control group,and the difference was statistically significant (x2=6.275,P=0.012<0.05).After treatment,the systolic blood pressure and diastolic blood pressure decreased in both groups compared with those before treatment;the observation group had systolic blood pressure of (123.12±8.94) mm Hg (1 mm Hg=0.133 kPa) and diastolic blood pressure of (81.75±7.15) mm Hg,which were lower than (136.16±9.46) and (90.14±8.36) mm Hg in the control group;the difference was statistically significant (P<0.05).After treatment,the scores of material function,physical status,social function and psychological function were improved in both groups compared with those before treatment;in the observation group,the material function score was (76.38±4.67) points,the physical status score was (73.73±4.27) points,the social function score was (78.48±5.75) points and the psychological function score was (84.22±4.74) points,which were higher than (62.48±5.05),(64.38±3.78),(71.25±4.76) and (74.64±4.62) points in the control group;the difference was statistically significant (P<0.05).After treatment,the blood viscosity,hematocrit and resistance index were decreased in both groups compared with those before treatment;in the observation group,the blood viscosity was (3.58±0.43) mPa·s,the hematocrit was (33.28±1.73)% and the resistance index was (0.25±0.07),which were lower than (4.44±0.36) mPa·s,(40.27±2.03)% and (0.56±0.07) in the control group;the difference was statistically significant (P<0.05).The follow-up results showed that the incidence of adverse pregnancy outcome in the observation group was 5.00%,which was lower than 22.50% in the control group,and the difference was statistically significant (P<0.05).Conclusion Nifedipine combined with rabetalol treatment for patients with PIH and preeclampsia can improve the blood pressure and umbilical artery hemodynamic indicators,enhance the quality of life,and improve the pregnancy outcomes of patients.

Pregnancy induced hypertensionPreeclampsiaNifedipineLabetalolQuality of lifePregnancy outcome

王婷、刘岩

展开 >

274700 郓城县人民医院产科

妊娠期高血压 子痫前期 硝苯地平 拉贝洛尔 生活质量 妊娠结局

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(21)